Developer of rapid diagnostic tests used to detect infectious diseases at the point of care, primarily through its Dual Path Platform (DPP) lateral flow technology. The company’s products have targeted conditions such as HIV, COVID‑19, and other global health threats, with customers that have includ...
3 members of Congress have disclosed 8 trades in Chembio Diagnostics, Inc. (CEMI), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 4 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-04-17 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2020-03-24 | Tom Malinowski | sell | $1K – $15K |
| 2020-03-19 | Tom Malinowski | sell | $1K – $15K |
| 2014-10-27 | Chris Collins | sell | $100K – $250K |
| 2014-10-14 | Chris Collins | sell | $1K – $15K |
| 2014-05-09 | Chris Collins | buy | $100K – $250K |
| 2014-05-09 | Chris Collins | buy | $15K – $50K |
| 2014-05-07 | Chris Collins | buy | $50K – $100K |